Group News

Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report reviewed provisional Group financial results for the year ended 30 June 2022. SALIENT FEATURES Revenue from continuing operations increased by 2% (+5% in constant exchange rate (“CER”)) to R38,6 billion (FY2021: R37,8 billion); Normalised EBITDA from continuing […]

Stephen Saad, Aspen Group Chief Executive Durban, South Africa - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA Operations”), has concluded a ten-year agreement (“the Agreement”) with Serum Institute of […]

Stavros Nicolaou, far left with students who gratefully received Aspen's donation of computers and tablets. Johannesburg - Aspen Pharmacare, a leading global specialty and branded multinational pharmaceutical company, has donated 25 computers and 30 tablets to Jiyana Secondary School which produced one of the top performing students in Ekurhuleni in 2021. This donation forms part of the “Gender […]

Stephen Saad, Aspen Group Chief Executive Durban - JSE listed company Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company, is positively positioned to respond as a third party for capacity fill opportunities following the World Health Organisation’s (WHO) declaration of monkeypox being a Public Health Emergency of International Concern (PHEIC). This […]

“Our purpose, To improve the health and quality of life of patients is closely aligned to the ethos of Mandela Day. This has been clearly demonstrated through our endeavours to provide citizens across the continent with vaccines which are manufactured in South Africa for Africa.”   Durban – JSE Limited listed Aspen Pharmacare Holdings Limited…